Skip to content

scaling for women with Polycystic Ovary Syndrome

Effect of Non-Surgical Periodontal therapy on serum follicular stimulating hormone, luteinizing hormone and interleukin-6 levels in women with Polycystic ovary syndrome - pcos management

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/06/034411
Enrollment
60
Registered
2021-06-28
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Non-Surgical Periodontal Therapy: Scaling which is a Non-Surgical periodontal therapy is given as intervention for both the groups (periodontitis and gingivitis) oral hygiene status is

Sponsors

Dr Nivedha k
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: POLYCYSTIC OVARY SYNDROME Women between 15 to 35 years of age and satisfy under "ROTTERDAM CRITERIA"

Exclusion criteria

Exclusion criteria: women with other systemic disorders women who has done scaling before 6 months

Design outcomes

Primary

MeasureTime frame
To determine levels of follicular stimulating, luteinizing hormone and interleukin-6 levelsTimepoint: 6 months

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactNivedha k

RAGAS DENTAL COLLEGE AND HOSPITAL

abi_aparna1986@yahoo.com09940268423

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026